Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 5…
- Recall date
- April 9, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0466-2024
- FDA classification
- Class III
- Brand / firm
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Sold / distributed
- USA nationwide.
Why it was recalled
Cross Contamination with Other Products
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
Get recall alerts
Free email alert whenever Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.